Mixed-phenotype acute leukemia treated with decitabine

Ji-Young LEE; Sang-Min LEE; Ja-Young LEE; Ki-Hyang KIM; Moon-Young CHOI; Won-Sik LEE.
The Korean Journal of Internal Medicine ; : 406-408, 2016.
Artículo en Inglés | WPRIM | ID: wpr-109554

Documentos relacionados

  1. Diagnostic workup of acute leukemias of ambiguous lineage.
  2. Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated Leukemia.
  3. T/myeloid MPAL: origin and pathogenesis.
  4. Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
  5. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
  6. Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.
  7. Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series.
  8. Deubiquitinating enzyme inhibitor alleviates cyclin A1-mediated proteasome inhibitor tolerance in mixed-lineage leukemia.
  9. Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: a case series.
  10. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.